Adiponectin and leptin levels correlate with body mass index and lipid fractions but not with disturbances of glucose metabolism

Acta Endocrinologica

Volumn 5, Issue 3, 2009, Pages 329-335

  Pop, D ^a,c   Zdrenghea, D ^a,c   Stanca, L ^b   Bodisz, G ^c   Petrovai, D ^a,c   Borz, B ^a,c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b BABE BOLYAI UNIVERSITY   (Romania)

^c Rehabilitation Hospital   (Romania)

Author keywords

Adiponectin; Diabetes; Leptin; Lipids; Obesity

Indexed keywords

EID: 70350692121     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2009.329     Document Type: Article

References (25)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919.
2. Pannacciulli N, Vettor R, Milan G, Grazotto M, Catucci A, Federspil G, De Giacomo P, Giorgino R, De Pergola G. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88:1748-1752.
3. Chandran M, Phillips SA, Ciaraladi T, Henry RR. Adiponectin more than just another hormone? Diabetes Care 2003; 26:224-50.
4. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109:2046-2049.
5. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004;323:630-635.
6. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. Adiponectin differentially regulate cytokines in porcine macrophages. Biochem Biophys Res Commun 2004; 316:924-929.
7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
8. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes 2003; 27(suppl):S25-28.
9. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26:2442-2450.
10. Barcaly L. Adiponectin may be a marker for type 2 dyabetes. Ann Intern Med 2008; 149:307-316.
11. Lau D, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288:H2031-H2041.
12. Friedman JM. Obesity in the new millennium. Nature 2000; 404:632-634.
13. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and Risk of Coronary Heart Disease in Older Men and Women. J Clin Endocrinol Metab 2008; 93:3357-3364.
14. Hajer GR, van der Graaf Y, Olijhoek JK, Edlinger M, Visseren FLJ. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Am Heart J 2007; 154:750.e1-750.e7.
15. Dekker J M, Funahashi T, Nijpels G, Pilz S, Stehouwer CDA, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008; 93:1489-1496.
16. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20:1595-1599.
17. Koh KK, Park SM, Quon JM. Leptin and cardiovascular disease. Response to therapeutic intervention. Circulation 2008; 117:3238-3249.
18. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7-hydroxylase (Cyp7a1) in leptin deficient (ob/ob) mice. J Biol Chem 2003; 278:42224-43228.
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
20. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7:941-946.
21. Martin SS, Qasim A, Reilly MP. Leptin Resistance: A Possible Interface of Inflammation and Metabolism in Obesity-Related. J Am Coll Cardiol 2008; 52:1201-1210.
22. Hopkins T, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74:11-18.
23. Rutter MK, Parise H, Benjanim EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PWF, Vasan RS. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex related difference in the Framigham Heart Study. Circulation 2003; 107:448-454.
24. Saraç F, Erdogan M, Zengi A, Köse T, Karadeniz M, Yilmaz C, Saygili F. Levels of adiponectin, TNF-α, and vascular cell adhesion molecule in the obese women with metabolic syndrome. Acta Endo (Buc) 2007; 3:405-416
25. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87(6): 2764-2769.